Mirati Therapeutics (MRTX) Earnings Date, Estimates & Call Transcripts → Like Tiny Crypto Retirement Funds (From Crypto 101 Media) (Ad) Free MRTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMRTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MRTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingAI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit Mirati Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($11.39) EPSNext Year EPS Consensus Estimate: ($9.81) EPS Mirati Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/6/2023Q3 2023($2.83)($2.49)+$0.34($2.49)$18.80 million$16.40 million8/8/2023Q2 2023($3.23)($3.04)+$0.19($3.04)$13.17 million$13.70 million 5/9/2023Q1 2023($3.47)($3.18)+$0.29($3.18)$4.80 million$7.17 million 2/28/2023Q4 2022($3.74)($3.51)+$0.23($3.51)$2.65 million$0.93 million 11/8/2022Q3 2022($3.46)($3.09)+$0.37($3.09)$4.72 million$5.43 million8/3/2022Q2 2022($3.53)($3.18)+$0.35($3.18)$2.20 million$5.36 million Get the Latest News and Ratings for MRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mirati Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/4/2022Q1 2022($3.37)($3.40)($0.03)($3.40)$0.18 million$0.71 million 2/28/2022Q4 2021($3.01)($3.72)($0.71)($3.72)$1.41 million$0.30 million 11/8/2021Q3 2021($2.87)($1.55)+$1.32($1.55)$1.41 million$71.79 million 8/5/2021Q2 2021($2.40)($3.23)($0.83)($3.23)--5/6/2021Q1 2021($2.13)($2.67)($0.54)($2.67)$0.17 million$0.01 million Mirati Therapeutics Earnings - Frequently Asked Questions How much revenue does Mirati Therapeutics generate each year? Mirati Therapeutics (NASDAQ:MRTX) has a recorded annual revenue of $12.44 million. How much profit does Mirati Therapeutics generate each year? Mirati Therapeutics (NASDAQ:MRTX) has a recorded net income of -$740.87 million. MRTX has generated -$12.22 earnings per share over the last four quarters. What is Mirati Therapeutics's EPS forecast for next year? Mirati Therapeutics's earnings are expected to grow from ($11.39) per share to ($9.81) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Perrigo Earnings Insmed Earnings Ultragenyx Pharmaceutical Earnings CymaBay Therapeutics Earnings Prestige Consumer Healthcare Earnings Organon & Co. Earnings Arrowhead Pharmaceuticals Earnings Amicus Therapeutics Earnings Alkermes Earnings Biohaven Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earningsBeyond Nvidia: The hidden stars with 200% earnings growth This page (NASDAQ:MRTX) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirati Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.